Silence Therapeutics
SLN
#6898
Rank
A$1.06 B
Marketcap
A$17.13
Share price
-3.94%
Change (1 day)
131.09%
Change (1 year)

EPS for Silence Therapeutics (SLN)

EPS in 2026 (TTM): A-$2.99

According to Silence Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.74. In 2025 the company made an earnings per share (EPS) of A-$2.65 a decrease over its 2024 EPS that were of A-$1.39.

EPS history for Silence Therapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.9912.49%
2025A-$2.6590.91%
2024A-$1.39-32.65%
2023A-$2.06-5.77%
2022A-$2.19-13.03%
2021A-$2.5210.23%
2020A-$2.2858.5%
2019A-$1.442.94%
2018A-$1.40969.59%
2017A-$0.13-79.18%
2016A-$0.63-3.11%
2015A-$0.65-55%
2014A-$1.443.83%
2013A-$1.39-84.88%
2012A-$9.19134.19%
2011A-$3.92-61.8%
2010A-$10.27-45.65%
2009A-$18.90-1.16%
2008A-$19.124.29%
2007A-$18.3410.54%
2006A-$16.59-22.29%
2005A-$21.35-57.32%
2004A-$50.0239.1%
2003A-$35.9670.67%
2002A-$21.07-25.17%
2001A-$28.165.29%
2000A-$26.74-24.54%
1999A-$35.4426.7%
1998A-$27.97-11.73%
1997A-$31.6972.24%
1996A-$18.40